5 rezultatus
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2013/001390 filed Nov. 15, 2013, which claims priority from Chinese Application No. 201210466262.8 filed Nov. 17, 2012, all of which are hereby
The present invention relates to platinum(II) complexes useful as anti-tumour agents, to a method for their preparation and to pharmaceutical compositions containing them.
BACKGROUND OF THE INVENTION
It is well known the wide interest on platinum(II) and Platinum(IV) complexes as anti-tumour
The invention relates to acid addition salts and/or solvates of [6-hydroxy-2-(4-hydroxyphenyl)benzol[1)]thien-3-yl][4-[2-(1-piperidinyl)-- ethoxy]phenyl-, raloxifene, having high availability from media comprising dilute hydrochloric acid, such as gastric juice. In addition useful crystal forms of
INCORPORATION-BY-REFERENCE OF MATERIAL ELECTRONICALLY SUBMITTED
Incorporated by reference in its entirety herein is a computer-readable nucleotide/amino acid sequence listing submitted concurrently herewith and identified as follows: 5,182 bytes ASCII (Text) file named "716371SequenceListing.txt,"
FIELD OF THE INVENTION
The invention relates a category of platinum containing compounds for treating cell proliferative diseases in particular, relates a serises of platinum containing compounds with the leaving group of malonic acid derivatives containing amino and alkyl amino radical, preparation